SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride for biomedical applications, is pleased to announce the successful completion of the first spine fusion surgery using the Valeo C+CSC with Lumen Interbody Fusion Device. The first surgery was performed by Dr.
DUBLIN, Aug. 20, 2018 /PRNewswire/ -- The "Minimally Invasive Surgical Instruments Market by Product, by Application, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2016-2023" report has been added to ResearchAndMarkets.com's offering. Global minimally invasive surgical instruments market is forecasted to attain revenue of $53.1 billion by 2023.The growth led by growing geriatric population, surge in
CAMBRIDGE, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the appointment of Jonathan Hopper as Chief Medical Officer. Dr. Hopper formerly served as Senior Medical Director, Orthopedic Clinical Development for Ferring Pharmaceuticals, where he was responsible
New York, NY, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Cartilage Repair/Regeneration Market by Treatment Modality (Cell-Based and Non-Cell Based), by Treatment (Cartilage Replacement and Cartilage Repair), by Type (Fibro Cartilage, Hyaline Cartilage, and Elastic Cartilage), and by End-Use (Ambulatory Surgical Centers, Hospitals & Clinics, Surgical Centers, and
BELGRADE, MT, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced the appointment of Kathie Lenzen as chief financial officer, effective August 20, 2018. Ms. Lenzen will report to Carl O’Connell, Xtant’s chief executive officer. “Ms.
17 August 2018 | By Ana Mulero In a comment submitted on the US Food and Drug Administration’s (FDA) recent action plan to promote medical device safety, the Advanced Medical Technology Association (AdvaMed) raised several concerns with the merit and logistics of the proposal. The five-pronged action plan—revealed in April—consists of establishing a medical device safety net,
NEW YORK and CANTON, Mass., Aug. 17, 2018 /PRNewswire/ -- Avista Healthcare Public Acquisition Corp. (NASDAQ :AHPA ) ("AHPAC"), a publicly traded special purpose acquisition company, and Organogenesis Inc. ("Organogenesis" or the "Company"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced that
August 16, 2018 SAN DIEGO--(BUSINESS WIRE)--KFx Medical, LLC. announced it has sued Stryker, Inc. (NYSE: SYK) for its continued infringement of US Patent number 7,585,311 and related patents for knotless double row rotator cuff repair. In 2015, when KFx successfully defended these patents versus Arthrex, Inc., Arthrex paid in excess of $35m in damages and
August 16, 2018 ST. LOUIS--(BUSINESS WIRE)--CoreLink, LLC, a vertically integrated manufacturer of spinal implant systems, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market The FoundationTM 3D Anterior Lumbar (ALIF) Interbody device. This marks the launch of the latest addition to CoreLink’s Foundation 3D Interbody Cage family. Jay Bartling, CEO, said,
Lund, Sweden, 18:00 CET, 16 August 2018 - BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, announces that its antibiotic-eluting product CERAMENT G has been approved by Health Canada. CERAMENT G is the first and only CE-marked gentamicin-eluting injectable ceramic bone graft substitute on the market. CERAMENT G sales have been
